Global Oncology Commercial Leader & Launch Architect

SystImmune

Princeton (NJ)

On-site

USD 350,000 - 500,000

Full time

2 days ago
Be an early applicant

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Benefits offered by this job

Medical premium coverage
Dental/ Vision coverage
401(k) match

Job summary

SystImmune, a clinical-stage biopharma, seeks a Chief Commercial Officer to build and lead its global commercial strategy as it advances oncology programs toward commercialization. The CCO will shape launch planning, market access, and commercial infrastructure and lead a lean organization.

The ideal candidate has 15+ years in biopharma commercial leadership, proven US/global oncology launches, and a track record of building in-house capabilities within a growing biotech.

Qualifications

  • 15+ years of senior commercial leadership in biopharma, oncology preferred.
  • Led at least one US/global oncology product launch with market strategy responsibility.
  • Experience building global commercial orgs and pre-commercial biotech scale.

Responsibilities

  • Lead the development and execution of the global commercial strategy and launch plan for the lead oncology program, including positioning, go-to-market strategy, launch readiness, performance metrics, and post-launch optimization.
  • Define and build the global in-house commercial model for a specialized oncology market, including marketing, sales/key account management, market access, patient services, insights and analytics, and commercial operations.
  • Develop comprehensive pricing, market access, reimbursement, distribution, and patient access strategies across commercial and government payers, providers, health systems, and other key stakeholders.
  • Build and lead a lean, high-performing commercial organization and establish the infrastructure, capabilities, systems, and processes required to support launch and future portfolio growth.
  • Provide commercial leadership across the product lifecycle, including market assessment, target product profile development, indication prioritization, competitive positioning, forecasting, launch strategy, and lifecycle management.
  • Partner closely with cross function teams to incorporate commercial insights into development, regulatory, evidence-generation, and market access strategies.
  • Establish market research, competitive intelligence, forecasting, and commercial analytics capabilities to inform product strategy, launch planning, portfolio prioritization, and investment decisions.
  • Lead commercial assessments of pipeline programs, new indications, and business development opportunities, including market opportunity, competitive landscape, differentiation, revenue potential, and commercialization strategy.
  • Develop long-range commercial forecasts, revenue projections, and scenario analyses to support corporate planning, resource allocation, portfolio decisions, and long-term growth strategy.

Skills

oncology experience
global launches
leadership
commercial strategy
market access
financial analysis
executive communication
team building

Education

Bachelor’s degree
MBA or equivalent preferred

Job description

SystImmune, a clinical-stage biopharma, seeks a Chief Commercial Officer to build and lead its global commercial strategy as it advances oncology programs toward commercialization. The CCO will shape launch planning, market access, and commercial infrastructure and lead a lean organization.

The ideal candidate has 15+ years in biopharma commercial leadership, proven US/global oncology launches, and a track record of building in-house capabilities within a growing biotech.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Chief Commercial Officer
Chief Commercial Officer

SystImmune • Princeton (NJ)

On-site
USD 350,000 - 500,000
Medical premium coverage
Dental/ Vision coverage
401(k) match
US Oncology Commercial Leader
US Oncology Commercial Leader

Servier Pharmaceuticals • Boston (MA)

Hybrid
USD 350,000 - 450,000
US Oncology Commercial Leader (Hybrid, Unlimited PTO)
US Oncology Commercial Leader (Hybrid, Unlimited PTO)

Servier • Boston (MA)

Hybrid
USD 350,000 - 450,000
Incentive programs
401(k)
Unlimited time off
Chief Commercial Officer | Global Oncology Growth Leader
Chief Commercial Officer | Global Oncology Growth Leader

Summit Therapeutics, Inc. • Princeton (NJ)

On-site
USD 400,000 - 480,000
Bonus potential
Stock options
Benefits
Chief Commercial Officer, Life Sciences
Chief Commercial Officer, Life Sciences

Vida Group International • North Carolina

On-site
USD 350,000 - 650,000
Performance bonuses
Executive compensation package
Senior Vice President- Chief Commercial Officer
Senior Vice President- Chief Commercial Officer

SciMax Global, LLC • Princeton (NJ)

Hybrid
USD 180,000 - 250,000
Global Oncology Marketing Director — Strategy & Launch
Global Oncology Marketing Director — Strategy & Launch

Merck & Co. • Rahway (NJ)

Hybrid
USD 191,000 - 300,000
Annual bonus
Long-term incentive
Comprehensive benefits package
Global Oncology Strategy Director — Launch & Operations
Global Oncology Strategy Director — Launch & Operations

BeiGene • United States

Remote
USD 187,000 - 247,000
Equity awards
Employee Stock Purchase Plan
Medical, Dental, Vision benefits
+1
Global Commercial Strategy & Launch Lead – Oncology
Global Commercial Strategy & Launch Lead – Oncology

BeOne Medicines Ltd. • United States

Remote
USD 187,000 - 247,000
Medical, Dental, Vision
401(k)
Equity awards
+1
Senior US Oncology Brand & Launch Leader (Hybrid)
Senior US Oncology Brand & Launch Leader (Hybrid)

Bioliance Life Science Partners • Buffalo Grove (IL)

Hybrid
USD 250,000 - 350,000
Medical, dental, vision
FSA for medical and dependent care
HSA through HDHP
+2